Document:

EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
 VOTING
AGREEMENT 
 VOTING AGREEMENT (this “Agreement”), dated as of July 2, 2015, among Centene Corporation, a Delaware
corporation (“Parent”) and Jay M. Gellert (“Stockholder”). 
 WHEREAS, in order to induce Parent,
Chopin Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent, and Chopin Merger Sub II, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent, to enter into the Agreement and Plan of Merger,
dated as of the date hereof (as amended from time to time, the “Merger Agreement”), with Health Net, Inc., a Delaware corporation (the “Company”), Parent has requested Stockholder, and Stockholder has agreed, to
enter into this Agreement with respect to all shares of Company Common Stock (“Shares”) now or hereafter “beneficially owned” by Stockholder. 

NOW, THEREFORE, the parties hereto agree as follows: 

ARTICLE 1 
 VOTING
AGREEMENT; GRANT OF PROXY 
 Section 1.01 Voting Agreement.
Stockholder shall (a) appear at each meeting of the stockholders of the Company or otherwise cause all of the Shares beneficially owned at such time by Stockholder to be counted as present thereat for purposes of calculating a quorum, and
respond to each request by Parent for written consent, if any and (b) vote or cause to be voted (or deliver or cause to be delivered a written consent with respect to) all Shares beneficially owned at such time by Stockholder: (i) for the
adoption of the Merger Agreement, the Merger and other transactions contemplated by the Merger Agreement, and all agreements in furtherance of the Merger and any actions in furtherance thereof at any meeting of the stockholders of the Company, and
at any adjournment or postponement thereof, at which such Merger Agreement and other related agreements (or any amended version thereof), or such other actions, are submitted for the consideration and vote of the stockholders of the Company (or in
response to a request by the Company for written consent with respect thereto) and (ii) against (A) any Takeover Proposal and (B) any other corporate action the consummation of which would frustrate the purposes, or prevent or
materially delay the consummation, of the transactions contemplated by the Merger Agreement; provided that nothing contained in this Section 1.01 shall restrict Stockholder from taking any action in his capacity as a director, officer or
employee of the Company which is permitted to be taken pursuant to the Merger Agreement. 
 Section 1.02 Irrevocable Proxy.
Stockholder hereby revokes any and all previous proxies granted by Stockholder with respect to Shares beneficially owned by him as of the date of this Agreement. By entering into this Agreement, Stockholder hereby irrevocably grants a proxy
appointing, until the termination of this Agreement in accordance with Section 5.03, Parent as Stockholder’s attorney-in-fact and proxy, with full power of substitution and resubstitution, for and in Stockholder’s name, to vote, or
grant a written consent with respect to, any Shares beneficially owned by Stockholders in the manner contemplated by Section 1.01 if 

 
and only if Stockholder (i) fails to vote or (ii) attempts to vote such Shares in a manner inconsistent with Section 1.01. The proxy granted by Stockholder pursuant to this
Section 1.02 is irrevocable and is granted in consideration of Parent entering into this Agreement and the Merger Agreement and incurring certain related fees and expenses. Stockholder hereby affirms that such irrevocable proxy is coupled with
an interest by reason of the Merger Agreement. Notwithstanding the foregoing, the proxy granted by Stockholder pursuant to this Section 1.02 shall be revoked and terminated upon termination of this Agreement in accordance with its terms. 

ARTICLE 2 

REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER 

Stockholder represents and warrants to Parent that: 

Section 2.01 Authorization. The execution, delivery and performance by Stockholder of this Agreement and the consummation by
Stockholder of the transactions contemplated hereby are within the capacity of and have been duly authorized by Stockholder. This Agreement constitutes a valid and binding agreement of Stockholder and, assuming this Agreement constitutes a valid and
binding agreement of Parent, is enforceable against Stockholder, except as such enforceability may be limited by (a) applicable bankruptcy, insolvency, moratorium, reorganization or similar laws in effect that affect the enforcement of
creditors rights generally or (b) general principles of equity, whether considered in a proceeding at law or in equity. If any of the Shares beneficially owned by Stockholder constitute community property under applicable Law, this Agreement
has been duly authorized, executed and delivered by, and constitutes the valid and binding agreement of, Stockholder’s spouse. 

Section 2.02 Non-Contravention. The execution, delivery and performance by Stockholder of this Agreement and the consummation of
the transactions contemplated hereby do not and will not (i) violate any applicable Law or (ii) require any consent or other action by any Person under, constitute a default under, or give rise to any right of termination, cancellation or
acceleration or to a loss of any benefit to which Stockholder is entitled under any provision of any agreement or other instrument binding on Stockholder. 

Section 2.03 No Other Voting Agreements. None of the Shares beneficially owned by Stockholders are subject to any voting trust or
other agreement or arrangement with respect to the voting of such Shares (except as established hereby) or that would otherwise have the effect of preventing or disabling Stockholder from performing in any material respect any of its obligations
under this Agreement. 
 Section 2.04 Ownership. As of the date hereof, Stockholder is the beneficial owner of less than 5.0% of
the issued and outstanding Company Common Stock. Stockholder is the sole beneficial owner and has and will have at all times through the Closing Date sole beneficial ownership, sole voting power (including the right to control such vote as
contemplated herein), sole power of disposition, sole power to issue instructions with respect to the matters set forth in Article I hereof, and sole power to agree to all of the matters set forth in this Agreement, and has not (i) granted any
proxy inconsistent with this Agreement that is still effective, (ii) entered into any voting or similar agreement, or (iii) entered into any contract, option or other arrangement or 

  
 2 

 
understanding with respect to the direct or indirect Transfer (as defined below), in each case with respect to any of the Shares beneficially owned by Stockholder. 

ARTICLE 3 

REPRESENTATIONS AND WARRANTIES OF PARENT 

Parent represents and warrants to Stockholder that: 

Section 3.01 Authorization. The execution, delivery and performance by Parent of this Agreement and the consummation by Parent of
the transactions contemplated hereby are within the capacity of and have been duly authorized by Parent. This Agreement constitutes a valid and binding Agreement of Parent and, assuming this Agreement constitutes a valid and binding agreement of
Stockholder, is enforceable against Parent, except as such enforceability may be limited by (a) applicable bankruptcy, insolvency, moratorium, reorganization or similar laws in effect that affect the enforcement of creditors rights generally or
(b) general principles of equity, whether considered in a proceeding at law or in equity. 
 Section 3.02
Non-Contravention. The execution, delivery and performance by Parent of this Agreement and the consummation of the transactions contemplated hereby do not and will not (i) violate any applicable Law or (ii) require any consent or
other action by any Person under, constitute a default under, or give rise to any right of termination, cancellation or acceleration or to a loss of any benefit to which Parent is entitled under any provision of any agreement or other instrument
binding on Parent. 
 ARTICLE 4 

COVENANTS OF STOCKHOLDER 

Stockholder hereby covenants and agrees that: 

Section 4.01 No Proxies for or Encumbrances on Shares. Stockholder shall not, without the prior written consent of Parent,
directly or indirectly, (i) grant any proxies or enter into any voting trust or other agreement or arrangement with respect to the voting of any Shares or (ii) sell, assign, transfer, encumber or otherwise dispose of
(“Transfer”), or enter into any contract, option or other arrangement or understanding with respect to the direct or indirect Transfer of, any Shares during the term of this Agreement or (iii) create or permit to exist any Lien
that could prevent Stockholder from voting the Shares beneficially owned by him in accordance with this Agreement or from complying in all material respects with the other obligations under this Agreement. Any attempted Transfer of Shares in
violation of this Section 4.01 shall be null and void. 
 Section 4.02 Additional Shares. Stockholder agrees to promptly
notify Parent of any additional Shares he acquires beneficial ownership of after the date hereof. Any such Shares shall automatically become subject to the terms of this Agreement. In the event Stockholder acquires in excess of 5.0% of the issued
and outstanding Company Common Stock, Stockholder shall promptly notify Parent and cooperate in connection with any required filings with the United States Securities and Exchange Commission. 

  
 3 

 Section 4.03 No Solicitation. Stockholder hereby agrees that during the term of this
Agreement, Stockholder shall not take any action that Parent is otherwise then prohibited from taking under Section 5.4 of the Merger Agreement. 

Section 4.04 Disclosure. Stockholder hereby consents to and authorizes the publication and disclosure by the Company and Parent in
any press release or in the Joint Proxy Statement or other disclosure document required in connection with the Merger Agreement or the transactions contemplated thereby, of Stockholder’s identity, the nature of Stockholder’s commitments,
arrangements and understandings pursuant to this Agreement and such other information required in connection with such publication or disclosure. As promptly as practicable, Stockholder shall notify the Company of any required corrections with
respect to such information previously supplied by Stockholder to the Company or Parent hereunder, if and to the extent Stockholder becomes aware that any such information shall have become false or misleading in any material respect. 

Section 4.05 Appraisal Rights. Stockholder agrees not to exercise any rights (including under Section 262 of the General
Corporation Law of the State of Delaware) to demand appraisal of any Shares which may arise with respect to the Merger. 
 ARTICLE 5 

MISCELLANEOUS 

Section 5.01 Definitional and Interpretative Provisions.  

(a) Capitalized terms used but not defined herein shall have the respective meanings set forth in the Merger Agreement. 

(b) The words “hereof”, “herein” and “hereunder” and words of like import used in this Agreement shall refer to
this Agreement as a whole and not to any particular provision of this Agreement. The captions herein are included for convenience of reference only and shall be ignored in the construction or interpretation hereof. Any singular term in this
Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words
“without limitation”, whether or not they are in fact followed by those words or words of like import. “Writing”, “written” and comparable terms refer to printing, typing and other means of reproducing words (including
electronic media) in a visible form. References to any agreement or contract are to that agreement or contract as amended, modified or supplemented from time to time in accordance with the terms hereof and thereof. References to any Person include
the successors and permitted assigns of that Person. References from or through any date mean, unless otherwise specified, from and including or through and including, respectively. 

(c) For purposes of this Agreement, the term “beneficially owned” (and correlative terms) has the meaning ascribed to it in
Rule 13d-3 adopted by the Securities and Exchange Commission under the Exchange Act. 

  
 4 

 Section 5.02 Further Assurances. Parent and Stockholder will each execute and
deliver, or cause to be executed and delivered, all further documents and instruments and use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under
applicable Law, to consummate and make effective the transactions contemplated by this Agreement. 
 Section 5.03 Amendments;
Termination. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party
against whom the waiver is to be effective. This Agreement shall terminate upon the earliest to occur of (x) the termination of the Merger Agreement, (y) a Company Adverse Recommendation and (z) the receipt of the Company Stockholder
Approval (as defined in the Merger Agreement); provided, the termination of this Agreement shall not relieve any party of liability for any intentional and material breach prior to such termination. Upon any termination of this Agreement,
this Agreement shall thereupon become void and of no further force and effect, and there shall be no liability in respect of this Agreement or of any transactions contemplated hereby on the part of any party hereto. 

Section 5.04 Expenses. All costs and expenses incurred in connection with this Agreement shall be paid by the party incurring such
cost or expense. 
 Section 5.05 Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the
benefit of the parties hereto and their respective successors and assigns; provided that no party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other party hereto,
except that Parent may transfer or assign its rights and obligations to any Affiliate of Parent. 
 Section 5.06 Governing Law;
Submission to Jurisdiction. This Agreement shall be construed in accordance with and governed by the laws of the State of Delaware, without regard to the conflicts of laws rules thereof. Each of the parties hereto (a) irrevocably submits
itself to the personal jurisdiction of the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or
federal court within the State of Delaware) and any state appellate court therefrom within the State of Delaware in the event any dispute arises out of this Agreement, (b) agrees that it will not attempt to deny or defeat such personal
jurisdiction by motion or other request for leave from any such court, (c) agrees that it will not bring any action relating to this Agreement in any court other than such court, other than actions in any court of competent jurisdiction to
enforce any judgment, decree or award rendered by any such court, and (d) waives any right to trial by jury with respect to any suit, action or proceeding directly or indirectly related to or arising out of this Agreement. Each of the parties
hereto further agrees that notice sent via a nationally recognized overnight courier service to the address set forth below such party’s signature hereto shall constitute sufficient service of process and waives any argument that such service
is insufficient. Each of the parties hereto hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action related to or arising out of this Agreement, that
(x) the action in such court is brought in an inconvenient forum, (y) the venue of such action is 

  
 5 

 
improper or (z) this Agreement or the subject matter hereof may not be enforced in or by such court. 

Section 5.07 Counterparts; Effectiveness. This Agreement may be signed in any number of counterparts, each of which shall be an
original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received counterparts hereof signed by all of the other parties hereto.
Until and unless each party has received a counterpart hereof signed by the other party hereto, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement
or other communication). 
 Section 5.08 Severability. If any term, provision or covenant of this Agreement is held by a court
of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions and covenants of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

 Section 5.09 Specific Performance. The parties hereto agree that irreparable damage would occur in the event any provision of
this Agreement is not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof in addition to any other remedy to which they are entitled at law or in equity (without a
requirement for posting of a bond in connection therewith). Each party agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that (a) the other party has an adequate remedy at
law or (b) an award of specific performance is not an appropriate remedy for any reason at law or equity. 
 Section 5.10
Entire Agreement; No Third-Party Beneficiaries. This Agreement constitutes the sole and entire agreement of the Stockholder and Parent with respect to the subject matter contained herein, and supersedes all prior and contemporaneous
agreements with respect to such subject matter. This Agreement is for the sole benefit of and may be enforced solely by Parent, and nothing in this Agreement, express or implied, is intended to or shall confer upon any person (other than Parent) any
legal or equitable right, benefit or remedy of any nature whatsoever. 
 Section 5.11 Ownership Interest. Nothing contained in
this Agreement shall be deemed to vest in Parent any direct or indirect ownership or incidence of ownership of or with respect to any Shares beneficially owned by Stockholder. All rights, ownership and economic benefits of and relating to such
Shares shall remain vested in and belong to Stockholder, and Parent shall not have any authority to direct the Stockholder in the voting or disposition of such Shares except as otherwise provided herein. 

Section 5.12 Capacity. Stockholder is entering into this Agreement solely in his capacity as the record holder or beneficial owner
of the Shares and nothing herein shall limit or affect any actions taken by Stockholder in his capacity as director or officer of the Company. 

[Remainder of this page intentionally left blank] 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the
day and year first above written. 
  

			
	Centene Corporation
		
	By:		 /s/ Jeffrey A. Schwaneke

			Name: Jeffrey A. Schwaneke
			Title: Senior Vice President, Corporate Controller and Chief Accounting Officer
	
	 /s/ Jay M. Gellert

	Jay M. GellertEXHIBIT 10.13

 

SUMMARY TERM SHEET

For Discussion Purposes Only

This Summary Term Sheet (the "Term Sheet") sets forth the principal terms pursuant to which, subject to certain conditions set forth herein, The Investor would agree to purchase certain securities of Fresh Healthy Vending International, Inc. (the "Company" or "VEND"), and the Company would sell such securities to the Investor (the "Transaction"). The terms and conditions set forth herein are subject to change and this Term Sheet does not constitute an offer. Except for the paragraph entitled "No Short Sales"; nothing in this Term Sheet is binding on either of the parties. The issuance and sale of such securities is subject to completion of ongoing due diligence to the Investor's satisfaction, the preparation of definitive documentation that is mutually satisfactory to the parties and, in the case of the Investor, that the Investor shall have determined that, subsequent to the date hereof and prior to the closing of the Transaction, there shall have been no material adverse developments relating to the business, assets, operations, properties, condition (financial or otherwise) or prospects of the Company and its subsidiaries. It is contemplated that the Company is offering the securities on a best efforts, confidential, private basis to the Investor, which is an accredited investor, pursuant to the exemption afforded by Rule 506(b) of Regulation D of the Securities Act of 1933, as amended.

Company                                        Fresh Healthy Vending International, Inc., a Nevada corporation.

		Business	Fresh Healthy Vending International, Inc., a franchise development company, and its franchisees, operate approximately 2,300 vending machines that provide natural, organic, and healthy food and beverage products in North America, the Bahamas, and Puerto Rico. The Company and its franchisees also offer food and beverage vending products through an Ecommerce platform. The company is headquartered in San Diego, California.

	 	
Units Offered

	
Dollar Amount

	
$600K of Units

	
Securities

	
Unit comprised of:

(i)  10% Convertible Promissory Notes; and

(ii)    100% Common stock purchase warrants (the "Warrants") coverage, with a term of 4 years, exercisable 6 months after issuance with a warrant strike price of $0.75 per share price of the Company's common stock. Warrants will have a cashless exercise feature.

	
Purchase Price

	
$50,000 Principal Amount of Note with 1⁄2 Notes available

	
Maturity Date

	
12 months with a one-time 3 month extension at election of Company.

In the event of extension, interest will be increased to 13% and shares equal to 3% of the conversion shares valued at $.30 per share shall be immediately issued.

	
Conversion

	
The Convertible Notes, plus accrued interest, may be converted at any time in whole or in part, at the lesser of:

(i)            25% discount to the next round of financing prior to conversion in excess of $1M; or

(ii)            $0.30 per share; or,

(iii)            Commencing 6 months after issuance date, at the Investor's sole discretion, at 20% discount to the lowest trading price 10 business days prior to conversion.

	
Registration Rights

	
Piggyback Registration Rights.

	
Anti-Dilution

	
There will be a full ratchet, anti-dilution with respect to the shares of Common Stock only (no adjustments will be made to the Warrants), for any equity or Convertible Debt financing completed or a definitive Term Sheet exercised within 12 months of closing or 15 months if the Company exercises its one-time extension (see "Term" below). The ratchet does not come into effect for any non-convertible debt offering only arranged by the Company, its advisors or bankers. In addition, the Company agrees NOT to accept any "floorless" Convertible Debt financing during the Term of the Notes, and acceptance of any such type of instrument will be considered a default of the Note.

	
Interest

	
10%,

13% in the event of the 3 month extension, Thereafter, 18 % in the event of a default,

Interest shall be adjusted so that it does not exceed the maximum interest rate permissible by law.

Interest payable in cash or kind with the election to the Noteholders.

Interest paid in kind shall be at the lesser of $0.30 or the 3 day low average of the 10 day proceeding closing bid price prior to the date the interest is due.

	
Events of Default

	
To be discussed.

	
Protective Provisions*

	
For so long as any portion of the Notes or at least 40% of the Conversion Shares are owned by the Investor(s), the Company shall not, absent consent of the majority in interest of the Investors:

(i)          make any loan or advance in excess of $100,000 to any person or entity;

(ii)          guarantee any indebtedness of any person or entity other than the Company or its wholly owned subsidiaries or enter into any transaction or agreement with any officers, directors or affiliated parties;

(iii)          make any investment in securities other than wholly owned subsidiaries or regular money market facilities

(iv)          incur any aggregate indebtedness in excess of $250,000 that is not already included in a Board-approved budget;

(v)    hire, fire, or change the compensation of the executive officers or management, including approving any option grants thereto;

(vi)          change the principal business of the Company, enter new lines of business, or exit the current line of business;

(vii)          sell, assign, license, pledge or encumber material technology or intellectual property except in the ordinary course of business, consistent with past practice;

 

  

	 	
(viii)          enter into any corporate strategic relationship involving the payment, contribution or assignment by the Company or to the Company of assets greater than $250,000;

(ix)          decide to liquidate, dissolve, wind up, merge or consolidate the Company; or

(x)          sell, lease, transfer, license or dispose of all or substantially all of the assets of the Company, except that notwithstanding this subsection and sub section

(ix) above, any merger, consolidation and/or sale of all or substantially all of the Company's assets or shares.

* Aforementioned applicable until conversion, and see Nick Yates Employment Agreement re indebtedness.

	
Use of Proceeds

	
General Working Capital with only up to $500,000 to repay outstanding senior indebtedness.

		SEC Filings	The Company will be responsible for timely filing of all required documents including Form D, and blue sky filings, and will pay for all legal opinions of Company counsel associated with all future Rule 144 sales of the Investor with respect to the securities sold.

		Opinion of Counsel	At closing, and among other deliverables customary for a financing of this kind (officer and secretary certificates, updated financial statements etc.), counsel for the Company shall issue an opinion reasonably satisfactory to the Investor, opining as to the due authorization and issuance of the Notes and Warrants, the reservation and approval of issuance of the common stock underlying the Warrants upon conversion of any part of the Notes, exercise of the Warrants (the "Warrant Shares"), and that all common stock issued or issuable is fully paid and nonassessable.  The "Transaction Documents" shall include, the Subscription Agreement, Note and Warrant issued to Investors. The specific opinion matters to be opined on are as follows (with specific language to be approved by counsel for Investor):

		1.	The Company (and its subsidiaries) is a corporation validly formed and in good legal standing under the laws of an acceptable state. The Company has the corporate power to own, lease and operate its properties and to conduct its business as described in the Offering Documents. The Company has (a) the corporate power to execute, deliver and perform its obligations, (b), taken all corporate action necessary to authorize the execution, delivery and performance, and (c) duly executed and delivered the Transaction Documents. The company owns marketable title to all of its subsidiaries.

		2.	The Transaction Documents have been duly authorized and are valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms.

		3.	No authorization, approval, consent or license of any U.S. governmental or regulatory body, agency or instrumentality is required in connection with the authorization, issuance, transfer, sale or delivery of the Convertible Promissory Notes and Warrants, the Selling Agent's Warrants, and the shares of Common Stock underlying the securities except as may be required pursuant to the federal securities laws and state blue sky laws.

		4.	The execution and delivery of the Transaction Documents by the Company, the consummation by the Company of the transactions therein contemplated and the compliance with the terms of the Transaction Documents do not and will not conflict with or result in a breach of any of the terms or provisions of, or constitute a default under, the certificate of incorporation or bylaws of the Company.

		5.	The conversion shares and warrant shares have been duly authorized and approved for issuance and, when issued upon conversion of the Notes and interest or exercise of the Warrants, will also be deemed validly issued, fully paid and non assessable in all respects.

		6.	The issuance of the Shares and the Warrants and entry into the Transaction Documents, does not conflict with or result in a breach of any of the terms or provisions of, or constitute a default under, the certificate of incorporation or bylaws of the Company.

		7.	The Company complied in all material respects with Regulation D of the Securities Act with regard to the Offering and the offering and sale of the Units were not required to be registered under the Securities Act.

		8.	No Litigation.

 

  

	
OTHER MATTERS

 

	
Governing law

	
The legal documents to be prepared shall be governed by the laws of the State of California; jurisdiction will be the State of California as well. Any controversy between the parties hereto involving the construction or application of any terms, covenants or conditions of this Agreement, or any claims arising out of or relating to this Agreement or the breach hereof or thereof, will be submitted to and settled by arbitration in San Diego, California, in accordance with the rules of the America's Arbitration Association that in effect, and judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. In the event of any arbitration under this Agreement, both parties agree to be responsible for and pay their own arbitration (i.e. filing) and legal fees, said failure to do so is to be considered an immediate default. In addition, upon default, Investor shall be entitled to recover all reasonable legal fees and miscellaneous costs incurred in the enforcement or collection of any judgment or award rendered therein.

	
No Short Sales

	
Following the execution of this Term Sheet and until the earlier of the exercise in full or expiration of the Warrants, neither the Investor nor any of its affiliates or members shall sell short any of the Company's securities or take any other action that would have the effect of depressing the value of the Company's common stock.

 

 

*REMINDER, ALL DEFINITIVE OFFERING DOCUMENTS SUBJECT TO COUNSEL REVIEW AND SATISFACTION

EXECUTED AS OF THIS 30th DAY OF JUNE, 2015

Fresh Healthy Vending International, Inc.

By /s/Arthur Scott Budman              

Name: Arthur Scott Budman 

Title: CEO

cc: Nicholas Yates

The Investor's Representative

By:  /s/Jeffrey Stuber                                                                            

Name: Jeffrey Stuber                      

Title: CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}]]